查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844070

机器人内视镜设备市场（依设备类型、应用、技术、最终用户和销售管道）——2025-2032年全球预测

Robotic Endoscopy Devices Market by Device Type, Application, Technology, End User, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，机器人内视镜设备市场规模将达到 125.9 亿美元，年复合成长率为 19.18%。

关键市场统计数据
基准年 2024 30.9亿美元
预计年份：2025年 37亿美元
预测年份 2032 125.9亿美元
复合年增长率 (%) 19.18%

简单介绍机器人内视镜的技术发展历程、临床应用的驱动因素以及影响各专科机器人内视镜发展的策略张力。

机器人内视镜领域融合了微创手术的创新和数位外科技术的拓展。近年来，致动器小型化、影像保真度和感测器整合的进步正在重塑临床医生对多个器官系统进行复杂诊断和治疗性介入的方式。因此，与传统内视镜平台相比，临床团队现在能够以更高的灵活性、更短的手术时间和更符合人体工学的方式完成手术。

技术进步，以及不断扩展的柔性及刚性平台乃至可吞嚥胶囊技术，正在拓宽临床适应症的范围，从支气管和耳鼻喉科手术到全面的胃肠病学和泌尿系统工作流程。这种多元化使设备供应商能够追求专业化的应用，而医疗机构则在评估机器人技术的应用路径，以期在临床效益和工作流程效率之间取得平衡。

监管预期、报销框架和医院采购优先事项的转变正在加速技术采纳的选择。因此，相关人员必须权衡临床结果与资本投入、培训路径和服务提供模式。本执行摘要的其余部分将综合这些动态，并为机器人内视镜领域的临床领导者、设备开发人员和商业策略家组装切实可行的建议。

分析技术创新、监管变革和商业模式的整合如何重塑临床工作流程和应用动态

在科技、临床和商业性力量的共同推动下，机器人内视镜领域正经历着一场变革。微型化的致动器和改进的触觉回馈使得在受限解剖结构中能够进行更精准的操作，而光学系统和人工智慧辅助视觉化技术的进步则增强了病灶检测和术中决策支援。这些技术并非孤立发展，它们正在重塑临床路径，使得更复杂的手术能够透过腔内途径完成，而无需采用传统的开放式或腹腔镜手术。

商业模式也在同步发展。设备开发商正在尝试基于结果的采购、服务合约以及包含培训和生命週期支援的捆绑式服务。医院和门诊医疗机构越来越重视整体拥有成本，而不仅仅是初始购置价格，更加重视能够支援跨多个手术领域的多种应用情境的模组化平台。同时，监管机构正在明确软体更新和人工智慧功能的开发路径，这将影响产品蓝图和上市后监管义务。

在操作层面，如何将创新技术整合到既有的临床工作流程中仍是重要的挑战，同时也蕴藏着巨大的机会。临床倡议者对于加速技术推广至关重要，但有效的培训课程、指导模式以及可验证的工作流程效率也同样重要。随着市场的成熟，医疗器材製造商、医疗系统和学术中心将携手合作，共同决定哪些创新技术能够从概念验证过渡到标准治疗阶段。

评估近期美国关税调整如何重塑全球供应链、筹资策略以及机器人内视镜相关人员的采购决策。

近期源自美国的政策变革和贸易行动，使全球医疗设备供应链的韧性以及先进治疗平台的成本结构再次成为焦点。关税调整可能对价值链上的多个环节造成压力，从精密组件和成像模组到成品组装，都会影响生产地点选择、关键子系统的采购方式以及战略伙伴关係伙伴的优先选择等决策。

为此，许多製造商正在加快供应商多元化，并推行近岸外包和区域製造策略，以减轻关税波动的影响。这些措施通常包括重新设计产品，以受影响地区更容易获得的替代品替代受关税影响的零件，以及与製造外包和物流供应商重新谈判商业条款。医疗机构和集团采购组织也已采取措施，审查其采购框架，以应对潜在的价格波动和专用设备前置作业时间延长的问题。

监管合规和进口单证操作已成为商业规划的核心，企业纷纷投资于海关专业知识，以最大限度地减少行政摩擦。同时，企业也在考虑其他策略，例如加强垂直整合和关键零件的双重采购，以维持供应的连续性。整体而言，关税相关压力带来的累积影响凸显了企业在不断变化的贸易环境下，必须具备韧性​​、灵活性和重组供应链的意愿，以保障产品供应并控制单位成本。

详细的細項分析揭示了设备类型、临床用途、平台技术、终端用户环境和销售管道如何驱动产品采用和差异化。

设备类型细分对于临床团队、采购集团和开发商如何确定投资优先顺序至关重要。诊断系统，包括可切片检查的设备和专用成像平台，因其能够在不造成显着组织损伤的情况下增强早期检测和病灶表征能力而备受重视。另一方面，治疗设备则着重于介入功能，例如消融、止血和切除，其机器人架构能够实现稳定、精确的能量传输和可控的组织操作。

应用主导的细分决定了临床工作流程和培训需求。支气管内平檯面临气道通路建立和感测器稳定性方面的挑战；胃肠道应用需要导航穿越近端和远端解剖结构；上消化道和下消化道手术对影像处理和器械输送的需求各不相同。耳鼻喉科和泌尿系统的应用对人体工学和器械设计提出了独特的要求，因此需要差异化的平台功能。

技术选择——胶囊式、柔性或刚性机器人内视镜——需要在患者舒适度、易用性和设备承重能力之间做出权衡。胶囊式系统强调非侵入性和诊断便捷性，柔性机器人平台优先考虑在复杂解剖结构中的操作范围和导航能力，而刚性平台则为特定的治疗性介入提供稳定性和动力。门诊手术中心寻求体积小巧、週转效率高的系统，诊所优化门诊诊断和转诊途径，医院优先考虑支援多学科诊疗的整合式手术室，而研究机构则优先考虑模组化和便于迭代开发的系统。销售管道也会进一步影响系统部署速度和支援力度，直销通路能够提供客製化的服务协议和销售模式，从而实现更广泛的地域覆盖和更大的扩充性。

区域说明医疗保健系统、法规环境和采购模式如何影响机器人内视镜创新技术的应用和规模

地理因素影响技术采纳週期、监管互动和商业化路径。在美洲，密集的学术医疗中心、大型综合医疗系统和私人门诊机构网路为早期临床检验和高触感商业模式提供了沃土。该地区的报销框架和机构采购流程影响着那些能够显着提高手术效率并带来可重复临床结果的平台的优先顺序。

欧洲、中东和非洲地区是一个异质性区域，其协调一致的监管环境、国家采购政策和多样化的医疗服务模式都会影响产品部署策略。在一些国家，集中采购和严格的卫生技术评估流程需要强有力的证据支持和本地临床合作；而在其他国家，分散采购和来自私营医疗机构的资本投资则能够加快产品部署速度。

亚太地区拥有种类繁多的医疗保健系统，从高度专业化的三级医疗中心到快速扩张的门诊网络，应有尽有。该地区的需求驱动因素包括消化器官系统和呼吸系统疾病的高发生率、对成本高度敏感的采购惯例，以及对国内製造和研发能力的不断增长的投资。在任何地区，将技术潜力转化为持续的临床应用都需要采取量身定制的方法，充分考虑当地的健保报销政策、临床实践模式和供应链因素。

从公司层级洞察决定产品差异化、临床证据取得、伙伴关係和竞争定位的营运措施。

机器人内视镜领域的竞争格局反映了成熟医疗设备製造商进军机器人领域与专注于颠覆性平台功能的灵活新兴参与企业之间的平衡。各公司的关键发展策略包括：透过研究者主导和赞助的研究来获取临床证据；开发整合服务和培训方案以减少实施阻力；以及与医院和学术中心合作，加速真实世界检验。

产品差异化将由独特的提案主张驱动，例如模组化设备生态系统、软体主导的可视化和决策支援，以及包含远端监控和预测性维护的全生命週期服务包。能够证明其产品与医院生态系统互通性、拥有完善的软体更新监管途径以及清晰的临床医生培训课程的公司，将在采购谈判中占据优势。

策略性企业措施包括对关键子系统进行选择性垂直整合、与影像处理和分析公司建立合作关係，以及重点投资于製造能力以确保供应的连续性。这些措施体现了企业对这一领域成功的务实认识：成功不仅需要卓越的临床表现，还需要可靠的售后支持以及在多元化医疗环境中实现商业性规模化的能力。

为开发者、医疗服务提供者和商业团队提供策略建议，以加速产品应用、降低供应风险并确保持续的临床价值。

产业领导者应优先考虑将设备创新与切实可行的推广策略结合的综合方法。首先，投资于强有力的临床证据项目，以解决支付方和医疗服务提供者重视的真实世界终点，并将培训路径融入商业部署中，以减少推广阻力。其次，透过区域采购、关键零件的双重采购以及与委託製造製造商合作，增强供应链韧性，最大限度地降低贸易中断和关税相关成本压力的风险。

第三，我们将设计符合医疗机构采购偏好的商业模式，提供灵活的资金筹措、基于绩效的服务以及可扩展的支援方案，这些方案将根据门诊中心、诊所和医院的具体情况量身定制。第四，我们将优先考虑互通性和支援持续改进的软体架构，以满足医疗设备软体的监管要求。最后，我们将与卓越临床中心和研究机构建立伙伴关係，以加速产品迭代改进，并建立引人注目的案例研究，从而为更广泛的报销和采购讨论提供支援。

透过执行这些优先事项，领导者可以加快采用速度，降低营运风险，并使平台能够在不同的医疗保健环境中产生持续的临床和商业性影响。

清晰的调查方法能够深入进行与主要相关人员的沟通、观察性分析以及辅助技术和监管审查，从而提供可操作的见解。

本执行摘要的研究综合基于多方法研究，结合了与主要相关人员的直接沟通以及技术和法规的辅助研究。主要资讯包括与临床负责人、采购主管和设备工程师进行的结构化访谈，以了解实际应用中的障碍、培训需求和组件采购实践。此外，还进行了有针对性的现场考察和监考环节的观察，以了解工作流程的影响和使用者体验的细微差别。

为了描述影响跨境贸易和医疗设备分类的技术趋势、监管指导和公共发展，我们参考了二级资讯来源。分析框架优先考虑将定性见解与已记录的监管决策和已发表的临床文献进行三角验证，以确保分析结果的稳健性。在适用情况下，我们运用情境评估来评估供应链中断、政策变化和技术成熟对商业计画的影响。

在整个研究过程中，我们着重假设的透明度、访谈通讯协定的清晰记录，以及对临床论点与已发表证据的严格对照审查。这种调查方法既支持切实可行的建议，也承认在某些领域需要进一步的原始研究或长期结果数据来增强决策的可靠性。

结论总结重点在于临床应用前景、实施的操作前提条件以及决定长期成功的策略要素。

机器人内视镜在微创医疗发展过程中占据着举足轻重的地位，它具有提高诊断准确性和进行更多介入治疗性介入的实际潜力。改进的驱动系统、先进的影像处理和智慧软体的融合，正在为支气管、胃肠道、耳鼻喉科和泌尿系统等多个诊疗领域带来应用释放，而多样化的平台技术则满足了不同的临床和操作需求。

然而，成功不仅取决于技术能力。持续推广应用需要精心设计的训练、协调供应商和厂商奖励机制的采购模式，以及能够抵御地缘政治和关税压力的稳健供应链。监管预期和报销机制的区域差异将继续影响哪些创新技术能够快速推广，哪些技术需要更长的验证期。

总之，下一阶段的发展将有利于那些兼具严谨的临床实务、卓越的营运能力、策略伙伴关係和适应性商业化策略的机构。整合这些能力的相关人员可以将技术前景转化为可衡量的临床和组织价值。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的电脑视觉和力回馈整合到机器人内视镜平台中
  • 开发用于靶向结肠筛检的磁驱动胶囊内视镜
  • 推广使用一次性机器人内视镜以降低内视镜手术中的感染风险
  • 推出一款用于机器人内视镜手术的远端手术平台，该平台具备即时医师指导功能
  • 加速一次性机器人胃镜和大肠镜核准的监管途径
  • 人工智慧息肉检测演算法的出现及其与机器人内视镜系统的集成
  • 采用先进的形状感应光纤可增强在复杂解剖结构中的导航能力。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：以设备类型分類的机器人内视镜设备市场

  • 诊断
    • 切片检查
    • 影像
  • 治疗
    • 消融
    • 止血
    • 切除

第九章 按应用分類的机器人内视镜设备市场

  • 支气管
  • 消化器官系统
    • 下消化道
    • 上消化道
  • 耳鼻喉科
  • 泌尿系统

第十章 依技术分類的机器人内视镜设备市场

  • 胶囊内视镜
  • 柔性机器人内视镜
  • 刚性机器人内视镜

第十一章 以最终用户分類的机器人内视镜设备市场

  • 门诊手术中心
  • 诊所
  • 医院
  • 研究所

第十二章 机器人内视镜设备市场（依销售管道划分）

  • 直销
  • 经销商

第十三章：按地区分類的机器人内视镜设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 机器人内视镜设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国机器人内视镜设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Intuitive Surgical, Inc.
    • Johnson & Johnson
    • Medrobotics Corporation
    • Olympus Corporation
    • FUJIFILM Holdings Corporation
    • HOYA Corporation
    • Medtronic plc
    • Boston Scientific Corporation
Product Code: MRR-CA17E905E71D

The Robotic Endoscopy Devices Market is projected to grow by USD 12.59 billion at a CAGR of 19.18% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.09 billion
Estimated Year [2025] USD 3.70 billion
Forecast Year [2032] USD 12.59 billion
CAGR (%) 19.18%

Concise introduction outlining technological evolution, clinical adoption drivers, and strategic tensions shaping robotic endoscopy across specialties

The field of robotic endoscopy sits at the intersection of minimally invasive procedural innovation and digital surgical augmentation. Recent advances in actuator miniaturization, imaging fidelity, and sensor integration have reshaped how clinicians approach complex diagnostic and therapeutic interventions across multiple organ systems. As a result, clinical teams are increasingly able to perform procedures with enhanced dexterity, reduced procedure times, and improved ergonomics compared with legacy endoscopic platforms.

Alongside technical progress, an expanding portfolio of flexible and rigid platforms, plus swallowable capsule technologies, has broadened clinical applicability from bronchial and otolaryngological procedures to comprehensive gastrointestinal and urological workflows. This diversification is enabling device suppliers to pursue specialized applications while healthcare providers evaluate pathways to adopt robotics where clinical benefit and workflow efficiency align.

Transitions in regulatory expectations, reimbursement frameworks, and hospital procurement priorities are accelerating adoption choices. Consequently, stakeholders must balance clinical outcomes with capital deployment, training pathways, and service delivery models. The remainder of this executive summary synthesizes those dynamics and frames practical considerations for clinical leaders, device developers, and commercial strategists operating in the robotic endoscopy space.

Analysis of converging technological innovations, regulatory shifts, and commercial models that are redirecting clinical workflows and adoption dynamics

The robotic endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. Miniaturized actuators and improved haptic feedback have enabled more precise manipulation in constrained anatomies, while advances in optical systems and AI-assisted visualization are enhancing lesion detection and intra-procedural decision support. These technology vectors are not acting in isolation; they are reshaping clinical pathways by enabling more complex interventions to be performed endolumenally rather than through open or laparoscopic approaches.

Commercial models are evolving in parallel. Device developers are experimenting with outcome-based procurement arrangements, service contracts, and bundled offerings that include training and lifecycle support. Hospitals and ambulatory providers are increasingly evaluating total cost of ownership rather than capital price alone, which places a premium on modular platforms that can support multiple use cases across procedural areas. Meanwhile, regulatory bodies are clarifying pathways for software updates and AI-enabled features, which has implications for product roadmaps and post-market surveillance obligations.

Operationally, integration into established clinical workflows remains a critical barrier and opportunity. Clinical champions are essential to accelerate adoption, but effective training curricula, proctoring models, and demonstrable workflow efficiencies are equally important. As the market matures, collaboration across device manufacturers, health systems, and academic centers will determine which innovations transition from proof-of-concept to standard of care.

Assessment of how recent United States tariff changes are reshaping global supply chains, sourcing strategies, and procurement decisions for robotic endoscopy stakeholders

Policy changes and trade measures originating from the United States in recent years have brought renewed attention to the resilience of global medical device supply chains and the cost structures of advanced procedural platforms. Tariff adjustments exert pressure across multiple nodes of the value chain, from precision components and imaging modules to finished assemblies, and they can influence decisions about where to manufacture, how to source critical subsystems, and which suppliers to prioritize for strategic partnerships.

In response, many manufacturers have accelerated supplier diversification and pursued nearshoring or regional manufacturing strategies to mitigate exposure to tariff volatility. These initiatives are often accompanied by redesign efforts aimed at substituting tariff-exposed components with alternatives that are readily sourced within target regions, and by renegotiated commercial terms with contract manufacturers and logistics providers. Healthcare providers and group purchasing organizations have also reacted by reassessing procurement frameworks to account for potential price variability and longer lead times for specialized instrumentation.

Regulatory compliance and import documentation practices have become more central to commercial planning, and firms are investing in customs expertise to minimize administrative friction. At the same time, alternative strategies such as increased vertical integration or dual-sourcing of critical components are being explored to preserve continuity of supply. Overall, the cumulative impact of tariff-related pressures has emphasized resilience, flexibility, and a willingness to reengineer supply chains to protect product availability and control unit costs under shifting trade conditions.

In-depth segmentation analysis clarifying how device type, clinical application, platform technology, end-user environment, and sales channel drive adoption and differentiation

Device type distinctions are central to how clinical teams, purchasing groups, and developers prioritize investments. Diagnostic systems, which encompass both biopsy-capable devices and imaging-focused platforms, are valued for their ability to enhance early detection and lesion characterization without extensive tissue disruption. Therapeutic devices, on the other hand, emphasize intervention capabilities such as ablation, hemostasis, and resection, where the robotic architecture can deliver stable, precise energy delivery and controlled tissue manipulation.

Application-driven segmentation determines clinical workflows and training requirements. Bronchial platforms face challenges related to airway access and sensor stabilization, while gastrointestinal applications require navigation across proximal and distal anatomy with distinct imaging and tool-delivery needs for upper and lower procedures. Otolaryngological and urological uses impose their own ergonomic and instrument-design constraints, reinforcing the need for differentiated platform features.

Technology choices-capsule endoscopes, flexible robotic endoscopes, and rigid robotic endoscopes-create trade-offs among patient comfort, controllability, and instrument payload. Capsule systems emphasize noninvasiveness and diagnostic convenience, flexible robotic platforms prioritize reach and navigation in tortuous anatomies, and rigid platforms deliver stability and force for certain therapeutic interventions. End-user settings influence purchasing rationale and support models; ambulatory surgical centers seek compact, turnaround-efficient systems, clinics optimize for outpatient diagnostics and referral pathways, hospitals focus on integrated suites that support multidisciplinary procedures, and research institutes prioritize modularity and access for iterative development. Sales channels further affect adoption speed and support intensity, with direct-sales approaches enabling tailored service agreements and distribution models offering broader geographic coverage and scalability.

Regional intelligence detailing how distinct healthcare systems, regulatory environments, and procurement models influence adoption and scaling of robotic endoscopy innovations

Geographic dynamics shape technology adoption cycles, regulatory engagement, and commercialization pathways. In the Americas, a dense network of academic medical centers, large integrated health systems, and private ambulatory facilities creates fertile ground for early clinical validation and high-touch commercial models. Reimbursement frameworks and institutional procurement processes in this region influence the prioritization of platforms that demonstrate clear procedural efficiency gains and reproducible clinical outcomes.

The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, national procurement policies, and diverse healthcare delivery models affect product rollout strategies. In some countries, centralized purchasing and rigorous health-technology assessment pathways require robust evidence generation and local clinical partnerships, while in others faster adoption is enabled by less centralized procurement and capital investment from private providers.

Asia-Pacific encompasses a wide spectrum of healthcare systems, from highly specialized tertiary centers to rapidly expanding ambulatory care networks. Demand drivers in this region include large patient volumes for gastrointestinal and bronchial conditions, cost-sensitive procurement practices, and increasing investment in domestic manufacturing and R&D capabilities. Across all regions, tailored engagement that respects local reimbursement realities, clinical practice patterns, and supply-chain considerations will be necessary to translate technological promise into sustained clinical use.

Strategic company-level insights on product differentiation, clinical evidence pursuits, partnerships, and operational moves that determine competitive positioning

Competitive dynamics in the robotic endoscopy space reflect a balance between established medical device incumbents expanding into robotics and agile newcomers focused on disruptive platform features. Key company strategies include pursuing clinical evidence generation through investigator-initiated and sponsored studies, developing integrated service and training bundles to reduce adoption friction, and forging partnerships with hospitals and academic centers to accelerate real-world validation.

Product differentiation is being driven by unique value propositions such as modular instrument ecosystems, software-driven visualization and decision-support, and lifecycle service packages that include remote monitoring and predictive maintenance. Firms that can demonstrate interoperability with hospital ecosystems, robust regulatory pathways for software updates, and clear clinician training curricula gain an advantage in procurement discussions.

Strategic corporate activity has included selective vertical integration of critical subsystems, alliances with imaging and analytics companies, and targeted investments in manufacturing capacity to secure supply continuity. These moves reflect a pragmatic recognition that success in this domain requires not only compelling clinical performance but also dependable post-market support and the ability to scale commercially in diverse healthcare environments.

Actionable strategic recommendations for developers, providers, and commercial teams to accelerate adoption, mitigate supply risk, and secure durable clinical value

Industry leaders should prioritize an integrated approach that aligns device innovation with pragmatic adoption strategies. First, invest in robust clinical evidence programs that address real-world endpoints valued by payers and providers, and ensure that training pathways are embedded into commercial rollouts to reduce adoption friction. Second, strengthen supply-chain resilience through regional sourcing, dual-sourcing arrangements for critical components, and partnerships with contract manufacturers to minimize exposure to trade disruptions and tariff-related cost pressures.

Third, design commercial models that reflect institutional purchasing preferences by offering flexible financing, outcome-linked services, and scalable support packages tailored to ambulatory centers, clinics, and hospitals. Fourth, emphasize interoperability and software architecture that supports continuous improvement while satisfying evolving regulatory expectations for software as a medical device. Finally, pursue partnerships with clinical centers of excellence and research institutes to accelerate iterative product refinement and build compelling case studies that support broader reimbursement and procurement discussions.

By executing against these priorities, leaders can reduce time-to-adoption, mitigate operational risk, and position their platforms for durable clinical and commercial impact across diverse healthcare settings.

Clear research methodology detailing primary stakeholder engagement, observational analysis, and secondary technical and regulatory review used to produce actionable insights

The research synthesis behind this executive summary is grounded in a multi-method approach that combines primary stakeholder engagement with secondary technical and regulatory review. Primary inputs included structured interviews with clinical leaders, procurement executives, and device engineers to capture real-world adoption barriers, training requirements, and component sourcing practices. These conversations were complemented by targeted site visits and proctoring session observations to understand workflow implications and user experience nuances.

Secondary sources were consulted to contextualize technological trends, regulatory guidance, and public policy developments affecting cross-border trade and device classification. The analytical framework prioritized triangulation of qualitative insights with documented regulatory decisions and published clinical literature to ensure robustness. Where applicable, scenario assessments were used to evaluate the implications of supply-chain disruptions, policy shifts, and technology maturation for commercial planning.

Throughout the process, attention was given to transparency of assumptions, clear documentation of interview protocols, and rigorous review of clinical claims against publicly available evidence. The methodology supports practical recommendations while acknowledging areas where further primary research or long-term outcomes data would strengthen decision confidence.

Concluding synthesis emphasizing clinical promise, operational preconditions for adoption, and the strategic attributes that will determine long-term success

Robotic endoscopy occupies a pivotal position in the broader trajectory of minimally invasive care, offering tangible potential to improve diagnostic accuracy and enable therapeutic interventions with lower patient burden. The convergence of improved actuation, advanced imaging, and intelligent software is unlocking applications across bronchial, gastrointestinal, otolaryngological, and urological care pathways, while diverse platform technologies are responding to varied clinical and operational needs.

Nevertheless, success will hinge on more than technical performance. Sustained adoption requires thoughtfully designed training, procurement models that align incentives for providers and vendors, and resilient supply chains that can withstand geopolitical and tariff-related pressures. Regional differences in regulatory expectations and reimbursement mechanisms will continue to shape which innovations scale rapidly and which require extended evidence-generation periods.

In sum, the next phase of development will favor organizations that combine clinical rigor with operational excellence, strategic partnerships, and adaptive commercialization strategies. Stakeholders who integrate those capabilities can convert technological promise into measurable clinical and organizational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven computer vision and force feedback in robotic endoscopy platforms
  • 5.2. Development of magnetically actuated capsule endoscopes for targeted colon screening procedures
  • 5.3. Expansion of single-use robotic endoscopes to mitigate infection risks in endoscopic procedures
  • 5.4. Adoption of remote telesurgery platforms for robotic endoscopy with real-time physician guidance
  • 5.5. Regulatory pathways accelerating approval of disposable robotic gastroscopes and colonoscopes
  • 5.6. Emergence of AI-based polyp detection algorithms integrated into robotic endoscopy systems
  • 5.7. Incorporation of advanced shape-sensing fiber optics for enhanced navigation in tortuous anatomy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Endoscopy Devices Market, by Device Type

  • 8.1. Diagnostic
    • 8.1.1. Biopsy
    • 8.1.2. Imaging
  • 8.2. Therapeutic
    • 8.2.1. Ablation
    • 8.2.2. Hemostasis
    • 8.2.3. Resection

9. Robotic Endoscopy Devices Market, by Application

  • 9.1. Bronchial
  • 9.2. Gastrointestinal
    • 9.2.1. Lower Gastrointestinal
    • 9.2.2. Upper Gastrointestinal
  • 9.3. Otolaryngological
  • 9.4. Urological

10. Robotic Endoscopy Devices Market, by Technology

  • 10.1. Capsule Endoscope
  • 10.2. Flexible Robotic Endoscope
  • 10.3. Rigid Robotic Endoscope

11. Robotic Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Robotic Endoscopy Devices Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distribution

13. Robotic Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Robotic Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Robotic Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Intuitive Surgical, Inc.
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Medrobotics Corporation
    • 16.3.4. Olympus Corporation
    • 16.3.5. FUJIFILM Holdings Corporation
    • 16.3.6. HOYA Corporation
    • 16.3.7. Medtronic plc
    • 16.3.8. Boston Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ROBOTIC ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ROBOTIC ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ROBOTIC ENDOSCOPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY LOWER GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UPPER GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY OTOLARYNGOLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ROBOTIC ENDOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ROBOTIC ENDOSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN ROBOTIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN ROBOTIC END